Intelgenx Technologies Corp is Shariah compliant. The company’s financials pass two standards and fail in three.
Ad
IGX – Intelgenx Technologies Corp
Compliant
★★☆☆☆
- Pharmaceuticals
- Toronto Stock Exchange
- July 16, 2022
$51,011,637
Market cap
100.59%
Revenue Growth
-
Analysts' Rating
AAOIFI
S&P
DJIM
FTSE
MSCI
AAOIFI
AAOIFI ✗
| Debt ÷ Market cap (MC) | 20.73% | ✓ |
| Non-Compliant Assets ÷ MC | 11.77% | ✓ |
| Impure Income (incl. Interest) | 9.9% | ✗ |
| Impure Income | % |
| Interest Income | 9.9% |
| Total | 9.9% |
S&P
S&P ✓
| Debt ÷ 36 mo MC | 24.76% | ✓ |
| Cash ÷ 36 mo MC | 9.24% | ✓ |
| AR ÷ 36 mo MC | % |
DJIM
DJIM ✓
| Debt ÷ 24 mo MC | 24.54% | ✓ |
| Cash ÷ 24 mo MC | 9.15% | ✓ |
| AR ÷ 24 mo MC | % |
FTSE
FTSE ✗
| Debt ÷ Assets | 59.07% | ✗ |
| Cash ÷ Assets | 22.03% | ✓ |
| Cash&AR ÷ Assets | 22.03% | ✓ |
| Impure Income (incl. Interest) | 9.9% | ✗ |
| Impure Income | % |
| Interest Income | 9.9% |
| Total | 9.9% |
MSCI
MSCI ✗
| Debt ÷ Assets | 59.07% | ✗ |
| Cash ÷ Assets | 22.03% | ✓ |
| Cash&AR ÷ Assets | 22.03% | ✓ |
Ad
N/A
1 = STRONG BUY | 2 = BUY | 3 = HOLD | 4 = UNDERPERFORM | 5 = SELL
Analysts’ Price Targets
Mean 0.8
Low: 0.8
High: 0.8
Total Analysts: 0
Company Profile
IntelGenx Technologies Corp. is a Canada-based drug delivery company. The Company is focused on the development and manufacturing of pharmaceutical films. The Company’s pharmaceutical film technologies include VersaFilm, DisinteQ, VetaFilm and transdermal VevaDerm, which allows pharmaceutical products that address unmet medical needs. The Company’s product pipeline offers various benefits to patients and physicians for many therapeutic conditions. Its VersaFilm research and development (R&D) services are based on a versatile drug delivery platform technology that enables the development of oral thin films exhibiting improved product performance. Its VetaFilm R&D services and veterinary oral films provide various market opportunities for improved drug delivery for companion animals. Its product portfolio includes RIZAPORT (Rizatriptan), EXORDIA (Tadalafil), Loxapine, Montelukast, Buprenorphine / Naloxone, and Dronabinol AdVersa (Dronabinol).
We do our best to screen stocks as accurately as possible. Please let us know in the comments if you spot an error or find something questionable. Jazaak Allahu khairan.
Responses